Traws Pharma, Inc. - Common Stock, par value $.01 per share (TRAW)

Historical Holders from Q3 2024 to Q3 2025

Symbol
TRAW on Nasdaq
Type / Class
Equity / Common Stock, par value $.01 per share
Shares outstanding
7.04M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
1.3M
Holdings value
$2.41M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
18
Number of buys
9
Number of sells
-5
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Traws Pharma, Inc. - Common Stock, par value $.01 per share (TRAW)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PERCEPTIVE ADVISORS LLC 9.99% 0% $1.64M $632K 887K +62.7% Perceptive Advisors LLC 30 Sep 2025
ORBIMED ADVISORS LLC 19.9% $1.16M 761K ORBIMED ADVISORS LLC 31 Dec 2024
Squadron Capital Management LLC 8.4% +40% $1.09M $316K 591K +40.5% Squadron Capital Management LLC 30 Sep 2025
Ikarian Capital, LLC 9.99% 0% $902K $299K 590K +49.5% Ikarian Capital, LLC 31 Mar 2025
Ayrton Capital LLC 9.9% $618K 404K Ayrton Capital LLC 31 Dec 2024
Adage Capital Management, L.P. 4.67% -26.1% $611K 330K 0% Adage Capital Management, L.P. 30 Sep 2025
Alyeska Investment Group, L.P. 9.9% $462K 302K Alyeska Investment Group, L.P. 31 Dec 2024

Institutional Holders of Traws Pharma, Inc. - Common Stock, par value $.01 per share (TRAW)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 1.3M $2.41M +$102K $1.85 18
2025 Q2 1.26M $1.87M -$1.08M $1.48 19
2025 Q1 1.73M $3.98M +$1.21M $2.30 18
2024 Q4 1.14M $10.1M +$4.4M $8.88 17
2024 Q3 646K $3.8M +$3.74M $5.88 10